BJH - 2018, issue Abstract Book BHS, february 2018
K. Imaeva , P. Vlummens MD, S. Verbeke , J. Philippé MD, PhD, I. Moors MD
BJH - 2018, issue Abstract Book BHS, february 2018
I. Moors MD, T. Kerre MD, PhD, B. Denys MD, M. Hofmans MD, PhD, K. Vandepoele PhD
BJH - 2018, issue Abstract Book BHS, february 2018
M. Hofmans MD, PhD, dr. A. Delie MD, K. Vandepoele PhD, N. Van Roy PhD, J. Van der Meulen , J. Philippé MD, PhD, I. Moors MD
BJH - volume 8, issue 4, august 2017
I. Moors MD
With the unraveling of the molecular basis of AML last year, new treatment options have arisen and new insights were established concerning disease response to therapy, its impact on prognosis and its relevance for post-remission treatment decisions.
(BELG J HEMATOL 2017;8(4):171–5)
Read moreBJH - volume 8, issue Abstract Book BHS, february 2017
V. Galle MD, S. Verbeke , W. Ceelen , I. Moors MD
BJH - volume 8, issue Abstract Book BHS, february 2017
I. Moors MD, P. Vlummens MD, C. Lecluyse , J. Vermassen
BJH - volume 7, issue 4, september 2016
I. Moors MD
The state of the art in acute myeloid leukaemia (AML) in 2016 is changing dramatically. This is the result of the availability of new techniques for genome sequencing leading to understanding of the AML ontogeny at the molecular level, redefining minimal residual disease status in daily practice, the optimised use of induction and post-remission strategies and the introduction of many novel agents. Hopefully this will ultimately lead to the long expected improvement in survival for our individual patients.
(BELG J HEMATOL 2016;7(4):137–42)
Read more
Top
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
